Blog
RSS FeedPosted by Michael Wonder on 25 Mar 2019
China pledges stronger reform on approving, monitoring new drugs
23 March 2019 - China pledged to improve its system for registering new drugs in the country this year and ...
Posted by Michael Wonder on 23 Mar 2019
Senate panel to hear from pharmacy middlemen on drug prices
21 March 2019 - The Senate Finance Committee said Thursday that it has secured commitments from executives of five major ...
Posted by Michael Wonder on 22 Mar 2019
Ontario may lift ban preventing major pharmacies from selling private-label generic drugs
21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...
Posted by Michael Wonder on 20 Mar 2019
Biosimilar groups offer proposals to help US better mirror EU successes
19 March 2019 - With 18 biosimilars approved in the US and just seven on the market, two biosimilars groups ...
Posted by Michael Wonder on 20 Mar 2019
Biosimilar approval and adoption in the U.S. needs to be expedited
20 March 2019 - Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999 and 2010. ...
Posted by Michael Wonder on 20 Mar 2019
Senate bill endorses Azar's call to allow drug imports
20 March 2019 - Bipartisan support for a Senate bill that seeks to allow drug importation to boost competition dovetails ...
Posted by Michael Wonder on 20 Mar 2019
FDA reform: it’s time to act, but not as an independent agency
19 March 2019 - In a rare exercise in bipartisan leadership, former FDA commissioners of both political parties called, in ...
Posted by Michael Wonder on 20 Mar 2019
Partisan squabbles shadow Congress' efforts to lower drug prices
20 March 2019 - It was supposed to be one of the few areas of bipartisanship. ...
Posted by Michael Wonder on 19 Mar 2019
Biosimilars Forum and Medicines for Europe call for changes to the US biosimilars market
19 March 2019 - The Biosimilars Forum and Medicines for Europe today released a joint white paper that discusses how Europe ...
Posted by Michael Wonder on 19 Mar 2019
Washington must change the system that encourages high drug prices
18 March 2019 -“Take away our rebates? We’ll just up premiums.” ...
Posted by Michael Wonder on 18 Mar 2019
Chile takes several ‘unorthodox’ steps to push back on drug prices, angering pharma
18 March 2019 - Searching for ways to beat back rising drug costs, the Chilean legislature is advancing three measures ...
Posted by Michael Wonder on 18 Mar 2019
The policy initiatives Scott Gottlieb championed at the FDA will remain after he departs
18 March 2019 - The resignation of Scott Gottlieb as commissioner of the Food and Drug Administration raises a big ...
Posted by Michael Wonder on 18 Mar 2019
CMA drops anti-competitive case against MSD
18 March 2019 - The Competition and Markets Authority has closed its investigation into a suspected anti-competitive discount scheme developed ...
Posted by Michael Wonder on 17 Mar 2019
What 1 April 2019 private health insurance changes mean for you
17 March 2019 - When the calendar flips to April 1 this year, many private health insurance customers will need ...
Posted by Michael Wonder on 17 Mar 2019
Statement from FDA Commissioner and Director of the Center for Devices and Radiological Health on efforts to evaluate materials in medical devices to address potential safety questions
15 March 2019 - We’re in an unprecedented era of innovation in medical devices with advances in materials science that ...